Pharmafile Logo
Pharmafocus logo
Advanced Search

melanoma

Showing 9 posts of 84 posts found.

Melanoma: new treatments and hopes

September 19, 2011
Research and Development advanced melanoma, melanoma, skin cancer

It usually starts with a subtle change of colour or shape in an existing mole. But if left undiagnosed and …

Feature
FDA

Roche skin cancer drug approval ‘imminent’

August 11, 2011
Sales and Marketing Roche, melanoma, vemurafenib

 Skin cancer treatment Zelboraf looks set to gain FDA approval months ahead of schedule. Roche and Daiichi Sankyo’s drug is …

News

BMS and Roche to team up in melanoma

June 3, 2011
Sales and Marketing BMS, Roche, melanoma, oncology

Bristol-Myers Squibb and Roche are to use two of their drugs in an exploratory phase I/II study a bid to …

News

New melanoma drug approved by FDA

March 28, 2011
Sales and Marketing BMS, melanoma

Yervoy, Bristol Myers Squibb’s new treatment for advanced skin cancer has gained approval in the US. The drug is the …

News

Daiichi Sankyo gains rights to potential blockbuster cancer drug

March 2, 2011
Research and Development BRAF protein, Daiichi Sankyo, PLX4032, Plexxikon, melanoma, personalised medicine

Daiichi Sankyo has purchased US-based discovery firm Plexxikon for $805 million, gaining access to its potential blockbuster melanoma drug PLX4032. …

News
Advanced melanoma

Melanoma: intense competition to be the next milestone treatment

February 9, 2011
Research and Development BRAF V600 mutation, Cancer, Tasigna, cancer research, melanoma, tremelimumab

A flurry of new data has emerged in the recent months from an industry-wide pipeline of cancer drugs which could …

Feature
GlaxoSmitKline's headquarters

GSK skin cancer drugs moves into phase III

January 25, 2011
Research and Development BRAF V600 mutation, Cancer, Duchenne Muscular Dystrophy, GSK, GSK1120212, GSK2118436, GSK968, GlaxoSmithKline, melanoma, skin cancer

GlaxoSmithKline has begun late-stage trials of two new drugs for advanced or metastatic melanoma patients. GSK2118436 and GSK1120212 are being …

News

Patient deaths halt Lilly cancer trial

December 15, 2010
Research and Development Eli Lilly, lilly, melanoma, skin cancer, tasisulam

Lilly has been forced to halt phase III trials of its melanoma candidate tasisulam due to serious safety concerns over …

News
Pfizer

Pfizer signs ‘personalised’ cancer collaboration

January 15, 2010
Research and Development Cancer, Debiopharm, Pfizer, melanoma, skin cancer, tremelimumab

Pfizer is to co-develop its monoclonal antibody treatment for advanced melanoma with Swiss company Debiopharm. The companies will conduct phase …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026